EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ROBIN: A unified nanopore-based assay integrating intraoperative methylome classification and next-day comprehensive profiling for ultra-rapid tumor diagnosis

Simon Deacon iD, Inswasti Cahyani iD, Nadine Holmes iD, Graeme Fox, Rory Munro iD, Satrio Wibowo, Thomas Murray, Hannah Mason, Mark Housley, Daniel Martin, Abdi Sharif, Areeba Patel iD und 6 weitere

Neuro-Oncology · 2025

DOI: 10.1093/neuonc/noaf103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Simon Deacon und 17 weiteren Autor:innen. Beteiligte Einrichtung: Nottingham University Hospitals NHS Trust, Nottingham, UK. Hauptthemen laut MEDLINE: DNA Methylation, Nanopore Sequencing, Biomarkers, Tumor, Epigenome. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Pathological Society of Great Britain and Ireland, British Neuropathological Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Advances in our technological capacity to interrogate CNS tumor biology have led to the ever increasing use of genomic sequencing in diagnostic decision making. Presently, CNS tumors are classified based on their epigenetic signatures, leading to a paradigm shift in diagnostic pathways. Such testing can be performed so rapidly using nanopore sequencing that results can be provided intraoperatively. This information greatly improves the fidelity of smear diagnosis and can help surgeons tailor their approach, balancing the risks of surgery with the likely benefit. Nevertheless, full integrated diagnosis may require subsequent additional assays to detect pathognomonic somatic mutations and structural variants, thereby delaying the time to final diagnosis.

Methods

Here, we present ROBIN, a tool based on PromethION nanopore sequencing technology that can provide both real-time, intraoperative methylome classification and next-day comprehensive molecular profiling within a single assay. ROBIN utilizes 3 methylation classifiers to improve diagnostic performance in the intraoperative setting.

Results

We demonstrate classifier performance on 50 prospective intraoperative cases, achieving a diagnostic turnaround time under 2 hours and generating robust tumor classifications within minutes of sequencing. Furthermore, ROBIN can detect single nucleotide variants, copy number variants, and structural variants in real time, and is able to inform a complete integrated diagnosis within 24 hours. Classifier performance demonstrated concordance with final integrated diagnosis in 90% of prospective cases.

Conclusion

Nanopore sequencing can greatly improve turnaround times for standard-of-care diagnostic testing and is furthermore able to reliably provide clinically actionable intraoperative tumor classification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationNanopore SequencingBiomarkers, TumorEpigenomeNanoporesCentral Nervous System NeoplasmsHumansHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

diagnosticsgliomaintraoperativemethylation classificationnanopore

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • School of Medicine, University of Nottingham, Nottingham, UK.
  • School of Life Sciences, University of Nottingham, Nottingham, UK.
  • Clinical Cooperation Unit Neuropathology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
  • Division of Neuropathology, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.
  • Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.

ORCID-Profile: Simon Deacon, Inswasti Cahyani, Nadine Holmes, Rory Munro, Areeba Patel, Sebastian Brandner, Felix Sahm, Simon Paine, Matthew Loose

Förderung

  • Wellcome Trust
  • Pathological Society of Great Britain and Ireland
  • British Neuropathological Society
  • Jean-Shanks Foundation

Zitieren

APA

Deacon, S., Cahyani, I., Holmes, N., Fox, G., Munro, R., Wibowo, S., Murray, T., Mason, H., Housley, M., Martin, D., Sharif, A., Patel, A., Goldspring, R., Brandner, S., Sahm, F., Smith, S., Paine, S., & Loose, M. (2025). ROBIN: A unified nanopore-based assay integrating intraoperative methylome classification and next-day comprehensive profiling for ultra-rapid tumor diagnosis. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf103

Vancouver

Deacon S, Cahyani I, Holmes N, Fox G, Munro R, Wibowo S, et al. ROBIN: A unified nanopore-based assay integrating intraoperative methylome classification and next-day comprehensive profiling for ultra-rapid tumor diagnosis. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf103

BibTeX
@article{Deacon2025,
  author = {Deacon, Simon and Cahyani, Inswasti and Holmes, Nadine and Fox, Graeme and Munro, Rory and Wibowo, Satrio and Murray, Thomas and Mason, Hannah and Housley, Mark and Martin, Daniel and Sharif, Abdi and Patel, Areeba and Goldspring, Robert and Brandner, Sebastian and Sahm, Felix and Smith, Stuart and Paine, Simon and Loose, Matthew},
  title = {ROBIN: A unified nanopore-based assay integrating intraoperative methylome classification and next-day comprehensive profiling for ultra-rapid tumor diagnosis},
  journal = {Neuro-Oncology},
  year = {2025},
  doi = {10.1093/neuonc/noaf103}
}
Kostenlos starten →